Vivos (RDGL) Gross Margin Growth (1y) (2011 - 2025)
Vivos (RDGL) Gross Margin Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.16 Bn | 176.87 Bn | 6.27 Bn | -67.00 |
| 2 | Stryker | 128.86 Bn | 125.98 Bn | 3.81 Bn | -54.00 |
| 3 | Medtronic | 108.89 Bn | 99.67 Bn | 6.41 Bn | 60.00 |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn | 62.00 |
| 5 | Edwards Lifesciences | 47.44 Bn | 43.76 Bn | 1.29 Bn | -65.00 |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.16 Bn | 1.98 Bn | -359.00 |
| 7 | Dexcom | 28.36 Bn | 27.24 Bn | 750.30 Mn | 610.00 |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn | 9.00 |
| 10 | Vivos | 27.57 Mn | 26.01 Mn | -3,105.00 | 9,326.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9,326.00 |
| Sep 30, 2025 | -70,363.00 |
| Jun 30, 2025 | -25,183.00 |
| Mar 31, 2025 | -62.00 |
| Sep 30, 2024 | -7,838.00 |
| Jun 30, 2024 | 5,861.00 |
| Mar 31, 2024 | -773.00 |
| Sep 30, 2023 | 20,054.00 |
| Jun 30, 2023 | -11,924.00 |
| Mar 31, 2023 | -10,252.00 |
| Sep 30, 2022 | -16,023.00 |
| Mar 31, 2015 | -145.00 |
| Mar 31, 2014 | 1,659.00 |
| Sep 30, 2013 | -5,243.00 |
| Mar 31, 2013 | 875.00 |
| Dec 31, 2012 | -122.00 |
| Sep 30, 2012 | -335.00 |
| Jun 30, 2012 | -2,597.00 |
| Mar 31, 2012 | -1,047.00 |
| Dec 31, 2011 | -1,474.00 |